Search results
Our enhanced FDA calendar integrates PDUFA dates, clinical trial primary completion dates, and working capital runway estimates into a single timeline that covers companies publicly traded in the U.S. facing upcoming PDUFA dates.
- Omniview
Analytics for Pharma and Biotech Traders. Omniview. Unified...
- Sign Up
Analytics for Pharma and Biotech Traders. Membership Levels....
- Products
Analytics for Pharma and Biotech Traders. Products. Screen...
- Support
User guides for our products are available here: Trial...
- Contact
We will respond to all inquiries within 24 hours. Phone: +1...
- Terms of Service
Without prejudice to FDA Tracker’s other rights under these...
- About
FDA Tracker was established in 2011 to help pharma and...
- Privacy Policy
Using Stripe’s payment technology, no sensitive data hits...
- Omniview
APTEKA forum and exhibition provides an opportunity to receive maximum useful information about all important events in the pharmaceutical industry, find new suppliers, place orders for the upcoming season, and acquire additional contacts for further mutually beneficial cooperation.
Dates: TBD. Venue: Moscow, Moscow, Russia. APTEKA is a priority exhibition in Russia that brings together all pharmaceutical industry participants: manufacturers and distributors of medicines and medical products, representatives of pharmacies and pharmacy chains, medical practitioners, new drug developers, and healthcare authorities.
30 lis 2022 · List of FDA New Drug Approvals 2022. The rest of the article reviews each drug product, including its indications, manufacturer, potential competitors, the commencement dates of each phase of clinical trials, and sales revenue (to be updated through 2023).
5 gru 2022 · Here we list all biopharmaceuticals approved from January 2018 to June 2022, examining what types of product reached the US and EU markets as well as the indication for which they were...
The FDA target date (PDUFA date) for completion of the review is April 27, 2023. PRINCETON, NJ and DEERFIELD, IL - September 13, 2022 - Otsuka America Pharmaceutical, Inc., (Otsuka) and H. Lundbeck A/S (Lundbeck) announce the U.S. Food and Drug Administration (FDA) acceptance of their New Drug Application (NDA) for aripiprazole 2-month, ...
May 17-19, 2022. Experts predict macro changes and technology advances to deliver post pandemic boom in the USA, with a ‘supercharged’ period for partnering, strategic alignment and contract agreements. Introduction.
